Navigation Links
Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
Date:11/3/2008

Combined Company Renamed Cornerstone Therapeutics Inc. and to Continue Trading on NASDAQ under "CRTX"

CARY, N.C., Nov. 3 /PRNewswire-FirstCall/ -- Cornerstone BioPharma Holdings, Inc., a specialty pharmaceutical company focused on developing and commercializing prescription medications for respiratory disorders, today announced the completion of its previously announced merger with Critical Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing innovative products for respiratory and inflammatory diseases. The combined company has been renamed Cornerstone Therapeutics Inc. and will continue to trade on The NASDAQ Capital Market under the ticker symbol "CRTX".

Under the terms of the merger, which is a stock-for-stock merger intended to qualify as a tax-free reorganization, all outstanding shares of Cornerstone BioPharma's common stock were converted into and exchanged for the right to receive shares of Critical Therapeutics' common stock, and all outstanding Cornerstone BioPharma options and warrants were assumed by Critical Therapeutics and became options and warrants to acquire Critical Therapeutics' common stock.

Immediately prior to the consummation of the merger, Critical Therapeutics effected a 10-to-1 reverse stock split of its common stock. As a result of the reverse stock split and the merger, Cornerstone BioPharma's and Critical Therapeutics' stockholders now own approximately 70 and 30 percent of the combined company's common stock, respectively, after giving effect to shares issuable under outstanding Cornerstone BioPharma options and warrants, but excluding shares issuable under outstanding Critical Therapeutics options and warrants.

Craig A. Collard, president and chief executive officer of Cornerstone BioPharma, will be president and chief executive officer of the combined company. Brian Dickson, M.D., chief medical officer of Cornerstone BioPharma, will be the chief medical officer
'/>"/>

SOURCE Cornerstone BioPharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25
2. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
3. PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
4. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
5. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
6. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
8. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
9. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
10. ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
11. CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... October 20, 2014 My Clients Plus ... software application. The new module enables easy administration ... full life-cycle quality care. , This application allows users ... their practice, attach a to-do item to a specific ... even set up reoccurring reminders for follow-ups. It's ...
(Date:10/20/2014)... October 20, 2014 Myoderm ... as Assistant Director of their CentralSource ... managing the innovative turnkey drug sourcing, distribution, and ... brings over 12 years of industry experience, in ... at the peak of their international success to ...
(Date:10/20/2014)... October 20, 2014 Based on ... the only imaging assays capable of determining DNA ... test.  With these three dimensions of high-resolution data, ... detect the widest range of disease-causing genetic rearrangements, ... by other genomic tools, including today’s advanced sequencing ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Unveiled at the ... Strategic Direction Scorecard conservatively estimates member hospital ROI on membership ... on dues, The Center provides $12.50 in value to member ... (Member Value – Member Dues)/Member Dues. , “This is ... this number and we think the methodology is really sound,” ...
(Date:10/20/2014)... October 20, 2014 Houston plastic surgeon ... the key elements of his innovative True Form ... plastic surgery residents and faculty at The University ... he, too, was once a medical student. Patronella, who ... private cosmetic plastic surgery practices in Texas, The ...
Breaking Medicine News(10 mins):Health News:My Clients Plus Announces New Workflow Management Software 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2
... , After prenatal diagnosis with complex birth defects, hundreds ... Special Delivery Unit at The Children,s Hospital of Philadelphia ... born in 2009 in the Garbose Family Special Delivery Unit ... 2010 with their joyful families. Families from 24 states traveled ...
... , LOS ANGELES, Dec. 29 The Criminal Defense ... premier Los Angeles Fraud Defense Firm, have successfully represented numerous ... allegations of Medi-Cal and Medi-Care theft. , The ... who are facing state and federal criminal fraud charges, as ...
... RIO DE JANEIRO, Dec. 29 ... Reuters: AMIL3.SA), the,largest managed care organization in Brazil, informs its ... meeting held today, approved the,payment of Interest on Capital Stock ... to the total amount of R$ 6.0 million. The payment,will ...
... Method may cut costs, but more review is needed, researchers ... to monitor intensive care unit patients from remote locations, as ... risk of death in patients or make it more likely ... , Researchers looked at the medical records of patients in ...
... your workout routine, even in foul weather , TUESDAY, Dec. ... even the most enthusiastic exerciser,s plans. It,s hard to get ... patches. And who wants to go to the gym when ... , But sticking to your exercise program throughout the colder ...
... , TUESDAY, Dec. 29 (HealthDay News) -- Many older adults ... a new study finds that the herbal product doesn,t stave ... a big trial in older people, we didn,t see any ... age-related changes of cognition," said lead researcher Dr. Steven T. ...
Cached Medicine News:Health News:Children's Hospital Brings Hope to Special Babies and Their Families 2Health News:Children's Hospital Brings Hope to Special Babies and Their Families 3Health News:Children's Hospital Brings Hope to Special Babies and Their Families 4Health News:Los Angeles Healthcare Fraud Defense Lawyers Announce Recent Results in California Medi-Cal and Medi-Care Criminal Law Cases 2Health News:Los Angeles Healthcare Fraud Defense Lawyers Announce Recent Results in California Medi-Cal and Medi-Care Criminal Law Cases 3Health News:Amilpar - Distribution of Interest on Capital Stock 2Health News: Winter Exercise Can Lift Your Spirits 2Health News:Ginkgo Won't Slow Decline of Aging Brain 2Health News:Ginkgo Won't Slow Decline of Aging Brain 3
(Date:10/19/2014)... Deutschland, October 19, 2014 ... Das Problem dabei ist, dass große ... der Kompetenz zu teilen. Es war ... freuen wir uns umso mehr, dass es uns ... Gepflogenheiten bei Kühlketten aufzuschreiben - mit einem Vorbehalt ...
(Date:10/17/2014)... 17, 2014  Training market researchers to spot ... factor in today,s highly competitive global marketplace. As ... that effectively and efficiently produce high performing analysts, ... Effective training programs can help ... from internal clients by developing analysts who can ...
(Date:10/17/2014)... -- UBM Medica US announces that Neurology Times ... resource for neurologists and other healthcare providers, features special coverage ... with discussions of the latest developments in approaches to diagnosis. ... disease , more than the total of those who have ... Diagnosis can be difficult because there are no confirmatory medical ...
Breaking Medicine Technology:Vergleichsbericht zu Pharma-Kühlketten und CRT 2Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3
... SRI International, an independent nonprofit research and development organization, ... International,s Center for Advanced Drug Research (CADRE) in Shenandoah ... head CADRE,s molecular diagnostic efforts, including its rare and ... experienced marketing and business development executive who has led ...
... 11, 2010 Arbor Pharmaceuticals, a specialty pharmaceutical company ... a $34.8 million financing.  This financing included a $17.5 ... Stock led by Signet Healthcare Partners, LLC.  The remainder ... term loan provided by several of the investing parties. ...
Cached Medicine Technology:Joseph Perrone Joins SRI International to Direct Molecular Diagnostics and Rare and Neglected Diseases Group 2Joseph Perrone Joins SRI International to Direct Molecular Diagnostics and Rare and Neglected Diseases Group 3Joseph Perrone Joins SRI International to Direct Molecular Diagnostics and Rare and Neglected Diseases Group 4Arbor Pharmaceuticals Completes $34.8 Million Financing 2Arbor Pharmaceuticals Completes $34.8 Million Financing 3
... Diagnostics offers Q Fever IFA Test Kits ... and IgM human antibody responses to Coxiella ... the simultaneous semi-quantitative detection and differentiation of ... Phase II antigens. By providing the two ...
Claes Shielded Retinotomy Scissors, Vertical...
... is intended for qualitatively detecting antibodies to ... The test is indicated for testing persons ... aid in the presumptive laboratory diagnosis of ... for self-testing, and this test is not ...
... test for the detection and semi-quantitation of ... Encephalitis virus (SLE), Western Equine Encephalitis virus ... California Encephalitis/La Crosse virus (CE). Each kit ... spots of SLE, WEE, EEE, and CE ...
Medicine Products: